Home | News & Analysis
Part B News
Your colleagues are sharing their dissatisfaction with a range of regulatory burdens, including insurance approval measures and federal quality programs, that cost medical practices time and money and equate to less attention and care they can provide to patients. 
Stay on guard against the emerging condition known as medical malpractice stress syndrome (MMSS), which can reduce providers’ self-esteem and boost their use of wasteful defensive medicine.
Understanding how to document and code for opioid use and abuse is critical to ensure accurate provider reimbursement. Also, remember that clinical data on opioid use is collected by the National Institute on Drug Abuse (NIDA) and other medical agencies to support research on strategies for preventing opioid misuse, treating opioid use disorders and managing pain.
Question: I saw a TV news story recently about how a doctor in Massachusetts treated patients in a parking lot when a power outage made her office unusable. “One patient, I saw in the car,” the doctor said. Was that a good idea? Shouldn’t they have sent their patients to another practice or rescheduled? 
The past three regulatory burden surveys from the Medical Group Management Association (MGMA) point to prior authorizations, Medicare’s Quality Payment Program (QPP) and audits and appeals as the biggest culprits in draining money and time from medical practices.


User Name:
Welcome to the new Part B News Online. If you are a returning user having trouble logging in, please click here.
Back to top